| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| AZD-9291 | 奥西替尼 | 1421373-65-0 |
| Dabigatran iMpurity L | 达比加群杂质L | 1422435-41-3 |
| Dabigatran Etexilate iMpurity C4 | 邻丁基达比加群乙酯(达比加群杂质) | 1416446-43-9 |
| (4aS,6aR,6bS,8aR,12aR,14bS)-methyl 11-bromo-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-octadecahydropicene-4a-carboxylate | (4aS,6aR,6bS,8aR,12aR,14bS)-methyl 11-bromo-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,12a,14,14a,14b-octadecahydropicene-4a-carboxylate | 1428550-98-4 |
| Dabigatran Impurity 14 | 达比加群杂质14 | 1422435-39-9 |
| Thieno[2,3-d]pyrimidine-3(2H)-acetic acid, 6-bromo-1,4-dihydro-α,α,5-trimethyl-2,4-dioxo-, 1,1-dimethylethyl ester | 2-(6-溴-5-甲基-2,4-二氧代-1,4-二氢噻吩并[2,3-D]嘧啶-3(2H)-基)-2-甲基丙酸叔丁酯 | 1434643-33-0 |
| (R)-2-(2-methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethan-1-ol | ND-646中间体 | 1434652-66-0 |
| Dabigatran iMpurity E | 达比加群杂质E | 1456889-80-7 |
| Nemorexant | 奈莫雷生 | 1505484-82-1 |
| PRN1008 | 1575596-29-0 | 1575596-29-0 |
| Dabigatran iMpurity K | 达比加群杂质K | 1580491-16-2 |
| 5-((2,4-dimethoxynaphthalen-1-yl)methylene)-2-thioxodihydropyrimidine-4,6(1H,5H)-dione | IT-901 | 1584121-99-2 |
| Dabigatran etexilate Impurity R | 达比加群乙二酸杂质R | 1610758-20-7 |
| Dabigatran iMpurity D | 达比加群杂质D | 1610758-22-9 |
| Roflumilast | 罗氟司特 | 162401-32-3 |
| BAR 502 | BAR 502 | 1612191-86-2 |
| (R)-4-fluoro-2-((3-methyl-2,4-dioxo-6-(piperidin-3-ylamino)-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile | 曲格列汀杂质 | 1812193-01-3 |
| Alogliptin Related Compound 14 | 苯甲酸阿格列汀杂质H | 1820685-30-0 |
| NETROPSIN DIHYDROCHLORIDE HYDRATE | 水合纺锤菌素氟安定 | 18133-22-7 |
| IPN-60090 | IPN-60090 | 1853164-83-6 |
